Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat

Smolders, EJ; Colbers, EPH; de Kanter, CTMM; Velthoven-Graafland, K; Drenth, JPH; Burger, DM

Smolders, EJ (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017; 72 (2): 486

Abstract

Background: Atazanavir is boosted with the cytochrome P450 (CYP) 3A4 inhibitor ritonavir. When combined with the CYP3A4 substrate daclatasvir, the dac......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索